Nov 10, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Here's Why Schrodinger ( SDGR ) Is a Great 'Buy the Bottom' Stock Now
Schrodinger (SDGR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Nov 05, 2025 • Zacks Commentary
NEUTRAL
Schrodinger, Inc. ( SDGR ) Reports Q3 Loss, Tops Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of +40.00% and +8.68%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 04, 2025 • Zacks Commentary
NEUTRAL
Tempus AI ( TEM ) Reports Q3 Loss, Tops Revenue Estimates
Tempus (TEM) delivered earnings and revenue surprises of +31.25% and +2.38%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 24, 2025 • Benzinga
SOMEWHAT-BULLISH
AI in Biotechnology Market to Reach $11.4 Billion by 2030
Boston, Oct. 24, 2025 ( GLOBE NEWSWIRE ) -- Artificial intelligence ( AI ) is transforming biotechnology, from accelerating drug discovery and streamlining clinical trials to enhancing diagnostics and genomic research.
Oct 21, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Strength Seen in Schrodinger ( SDGR ) : Can Its 13.8% Jump Turn into More Strength?
Schrodinger (SDGR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Sep 09, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Does Schrodinger ( SDGR ) Have the Potential to Rally 40.43% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 40.4% in Schrodinger (SDGR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.